CING
Cingulate Inc
NASDAQ · Pharmaceuticals
$7.70
+1.21 (+18.64%)
Open$6.75
Previous Close$6.49
Day High$7.75
Day Low$6.53
52W High$16.62
52W Low$6.85
Volume—
Avg Volume243.6K
Market Cap57.34M
P/E Ratio22.01
EPS$0.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+86.8% upside
Current
$7.70
$7.70
Target
$14.38
$14.38
$9.95
$14.38 avg
$17.66
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.37M | 8.17M | 9.32M |
| Net Income | 2.92M | 2.10M | 3.15M |
| Profit Margin | 34.9% | 25.8% | 33.8% |
| EBITDA | 4.25M | 3.98M | 4.18M |
| Free Cash Flow | 2.06M | 2.44M | 3.61M |
| Rev Growth | +14.6% | -6.6% | +11.6% |
| Debt/Equity | 0.37 | 0.32 | 0.41 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |